Aclaris Therapeutics Inc
NASDAQ:ACRS

Watchlist Manager
Aclaris Therapeutics Inc Logo
Aclaris Therapeutics Inc
NASDAQ:ACRS
Watchlist
Price: 3.03 USD -0.33% Market Closed
Market Cap: 328.3m USD

Intrinsic Value

The intrinsic value of one ACRS stock under the Base Case scenario is hidden USD. Compared to the current market price of 3.03 USD, Aclaris Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ACRS Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Aclaris Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

ACRS looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ACRS usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about ACRS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ACRS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Aclaris Therapeutics Inc.

Explain Valuation
Compare ACRS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ACRS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Aclaris Therapeutics Inc

Current Assets 100.6m
Cash & Short-Term Investments 95.9m
Receivables 4.7m
Non-Current Assets 74.9m
Long-Term Investments 71.3m
PP&E 3.2m
Other Non-Current Assets 406k
Current Liabilities 25.6m
Accounts Payable 9.2m
Accrued Liabilities 7.7m
Other Current Liabilities 8.7m
Non-Current Liabilities 29.8m
Other Non-Current Liabilities 29.8m
Efficiency

Free Cash Flow Analysis
Aclaris Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Aclaris Therapeutics Inc

Revenue
15.7m USD
Cost of Revenue
-15.1m USD
Gross Profit
626k USD
Operating Expenses
-153.9m USD
Operating Income
-153.3m USD
Other Expenses
11.6m USD
Net Income
-141.7m USD
Fundamental Scores

ACRS Profitability Score
Profitability Due Diligence

Aclaris Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Sustainable 3Y Average Gross Margin
Low Gross Margin
Declining Gross Margin
Declining Net Margin
hidden
Profitability
Score

Aclaris Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ACRS Solvency Score
Solvency Due Diligence

Aclaris Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

Aclaris Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ACRS Price Targets Summary
Aclaris Therapeutics Inc

Wall Street analysts forecast ACRS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACRS is 7.82 USD with a low forecast of 2.02 USD and a high forecast of 16.8 USD.

Lowest
Price Target
2.02 USD
33% Downside
Average
Price Target
7.82 USD
158% Upside
Highest
Price Target
16.8 USD
454% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Aclaris Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ACRS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ACRS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ACRS stock?

The intrinsic value of one ACRS stock under the Base Case scenario is hidden USD.

Is ACRS stock undervalued or overvalued?

Compared to the current market price of 3.03 USD, Aclaris Therapeutics Inc is hidden .

Back to Top